Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,186 recruiting studies in this area right now.
By phase
- Not applicable2,937
- Phase 2757
- Phase 1541
- Phase 3383
- Phase 1/Phase 2295
- Phase 4211
- Phase 2/Phase 362
Top conditions
- Breast Cancer1,227
- Melanoma182
- Rheumatoid Arthritis142
- Metastatic Breast Cancer140
- Atopic Dermatitis128
- Systemic Lupus Erythematosus125
- Breast Neoplasms120
- Triple Negative Breast Cancer117
- Colorectal Cancer93
- Ovarian Cancer92
- Psoriasis88
- Breast Carcinoma83
- Lung Cancer78
- Prostate Cancer70
- Rheumatoid Arthritis (RA)64
- Diabetic Foot Ulcer61
- Systemic Sclerosis60
- Cancer58
Leading sponsors
- Fudan University66
- M.D. Anderson Cancer Center52
- Memorial Sloan Kettering Cancer Center50
- Novartis Pharmaceuticals49
- Mayo Clinic42
- Assistance Publique - Hôpitaux de Paris41
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37
- AstraZeneca36
- National Cancer Institute (NCI)35
- Second Affiliated Hospital, School of Medicine, Zhejiang University30
Where studies are running
- California418
- Arizona159
- Florida132
- Alabama128
- New York110
- Texas107
- Massachusetts93
- Maryland91
- Pennsylvania76
- North Carolina68
Recruiting studies5,186 total
- NCT06555614Recruiting
Safety of a special mesh in breast reconstruction
This study tests if a special mesh called an acellular dermal matrix (SC DERM® Recon) is safe for women having breast reconstruction with implants after mastectomy for breast cancer. It involves careful follow-up to check for any problems.
Seoul, SeoulAges 19–79 - NCT06512571Recruiting
Heart changes in Fabry disease: an observational study
This study looks at people with Fabry disease, a genetic condition that can cause the heart muscle to thicken. Researchers want to understand how the heart's blood vessels change over time, which may help improve care for Fabry disease.
BeijingAges 18 years+ - NCT06510205Recruiting
Long-term safety of Mentor breast implants in Chinese women
This study follows women who have Mentor breast implants for 5 years to check their long-term safety. It collects information from your medical records and follow-up visits to monitor how the implants are doing.
ChengduAges 18–100 - NCT06258668Recruiting
Real-world study of Sotyktu for psoriasis in Korea
This study looks at how safe and effective a pill called Sotyktu is for people with moderate-to-severe plaque psoriasis in real-life medical settings in Korea. If you are 19 or older and are about to start Sotyktu for your psoriasis as your doctor prescribes, this study may be an option for you.
SeoulAges 19 years+ - NCT07250802RecruitingPhase 3
Long-term study of zasocitinib for children with plaque psoriasis
This trial tests a daily pill (zasocitinib) for children and teens with moderate to severe plaque psoriasis that hasn't been controlled by other treatments. It aims to see if the pill can safely improve skin symptoms over a long period.
Chula Vista, CaliforniaAges 4–17 - NCT07211542RecruitingPhase 2
Study of SHR-1905 for moderate-to-severe eczema
This trial tests a new drug called SHR-1905 for people with moderate-to-severe atopic dermatitis (a type of eczema). It aims to see if the drug is safe and helps improve symptoms.
Guangzhou, GuangdongAges 18–75 - NCT05732987Recruiting
Study genetics in inflammatory skin diseases involving neutrophils
This study looks at genetic differences in people with certain inflammatory skin diseases that involve a specific type of immune cell (neutrophils). Your participation may help researchers better understand why these conditions happen.
BaselAges 18–100 - NCT07471399Recruiting
Radiofrequency device for temporary face tightening
This study tests a radiofrequency device to tighten facial skin temporarily. It may be a treatment option for people who want non-surgical skin tightening.
SeoulAges 19–65 - NCT07221643Recruiting
Carotenoids, skin health and immune aging study
This study looks at how natural compounds in the skin called carotenoids relate to immune changes as we age. It compares younger and older healthy adults to understand aging better.
Redwood City, CaliforniaAges 18 years+ - NCT06328530Recruiting
Itch study using multiple itch-inducing substances
This study tests if applying several itch-causing substances at once makes you itch more. It is for healthy adults who want to help researchers understand itch better.
AalborgAges 18–60 - NCT06340438Recruiting
Itch and thoughts: a healthy volunteer study
This study looks at how your thoughts (specifically, catastrophizing) affect how intensely you feel itch. Healthy volunteers are asked to rate itch sensations after a mild stimulus, helping researchers understand the connection between thinking and feeling.
AalborgAges 18–60 - NCT06988618Recruiting
Real-world use of nemolizumab for adults with prurigo nodularis
This study looks at how well nemolizumab works in real-world settings for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. If you are starting this medication as part of your normal care, you may be able to join.
Birmingham, AlabamaAges 18 years+ - NCT06203249Recruiting
Exploring lung health and immune system in a rare muscle disease
This trial looks at how the immune system and tiny organisms in the lungs may affect a rare condition called anti-MDA5 positive dermatomyositis, which can cause serious lung disease. It may help doctors understand why some patients get worse quickly and how to better treat them.
Beijing, Beijing MunicipalityAges 18–100 - NCT07064330Recruiting
Blood test for immune markers in skin cancer patients on cemiplimab
This trial is testing whether a new blood test can predict how well the drug cemiplimab works for skin cancer and if it causes side effects. It may help doctors better match treatments to patients.
Salamanca, SalamancaAges 18 years+ - NCT07670858RecruitingPhase 1
Study of a new skin cream for basal cell carcinoma
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
Bowling Green, KentuckyAges 18–85 - NCT06791525RecruitingPhase 4
Testing a new wart cream for kids ages 8 to 18
This study is testing an ointment called tirbanibulin to treat warts on the hands of children and teens. It may offer a new option if other treatments haven't worked.
New City, New YorkAges 8–18 - NCT07228442RecruitingPhase 2
Study of L19IL2 and L19TNF for advanced skin cancer
This trial tests a combination of two drugs, L19IL2 and L19TNF, which are injected directly into skin tumors. It is for patients with advanced cutaneous squamous cell carcinoma that has not responded to or cannot tolerate immune checkpoint inhibitor therapy.
Orange, CaliforniaAges 18 years+ - NCT07204691Recruiting
Hyaluronic acid lip filler with lidocaine study
This study tests a new hyaluronic acid filler with lidocaine for making lips fuller. It is for healthy adults with thin lips who want a noticeable improvement.
MölndalAges 18 years+ - NCT07023952Recruiting
Phenol plus laser for pilonidal sinus healing study
This trial tests if adding phenol treatment to laser therapy helps the wound heal faster and better after treating pilonidal sinus (a small tunnel in the skin near the tailbone). It is for people who have this condition for the first time and have only a few sinus openings.
Istanbul, OtherAges 18 years+ - NCT06389071Recruiting
Laser treatment for lichen sclerosus
This study tests a laser treatment for women with vulvar lichen sclerosus to see if it can help with symptoms like itching, burning, pain, or soreness. It's a option for those who have had a biopsy to confirm the condition.
Val-d'Or, QuebecAges 18 years+ - NCT07340671Recruiting
Laser treatment for facial bumps in frontal fibrosing alopecia
This study tests whether laser therapy can help treat small bumps (papules) that appear on the face in people with frontal fibrosing alopecia, a type of hair loss. If you have these bumps and are generally healthy, you may be able to join.
Miami, FloridaAges 18 years+ - NCT07024602RecruitingPhase 1
Testing ASC50 tablets for plaque psoriasis
This study tests an investigational tablet called ASC50 for plaque psoriasis. It aims to see if it is safe and works well for people with this skin condition.
Miami, FloridaAges 18–65 - NCT07331181Recruiting
Studying a treatment for cheek and décolletage wrinkles
This trial tests two treatments called INNEA and INNEA AQUA for cheek and décolletage wrinkles. The goal is to see how well they work and if they are safe for women aged 35-65.
Brescia, BresciaAges 35–65 - NCT06382987Recruiting
Comparing deucravacitinib vs apremilast for plaque psoriasis
This study compares two oral medications, deucravacitinib and apremilast, for adults with plaque psoriasis in Japan. It looks at how well each drug works in real-world use.
Minato-ku, TokyoAges 18 years+
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,186 recruiting dermatology studies from the U.S. registry right now, out of 8,258 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.